← Open Payments lookup

REX LEAR: Open Payments

NPI 1962445999 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,815 in 105 payments from 14 companies in 2025. Trend: 2023 $1,490 · 2024 $1,510 · 2025 $1,815

Food & beverage: $1,711Education: $104
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.24$283
Otsuka America Pharmaceutical, Inc.23$265
Janssen Pharmaceuticals, Inc10$240
Vanda Pharmaceuticals Inc.9$225
Teva Pharmaceuticals USA, Inc.6$189
E.R. Squibb & Sons, L.L.C.7$187
Alkermes, Inc.9$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$82
ABBVIE INC.3$55
Lundbeck LLC3$47

Products named: INGREZZA, REXULTI, COBENFY, FANAPT, INVEGA SUSTENNA, ARISTADA, SPRAVATO, CAPLYTA.

Industry payments across KS — which companies pay providers there.